.png)
JHVEPhoto
Medical device manufacturer Medtronic (NYSE:MDT) plans to separate its diabetes business into a stand-alone company, according to a Wall Street Journal report, citing people familiar with the matter.
The new independent entity will be led by Que Dallara, the current
English (US) ·